BridgeMD
New treatment option for HIV Viremia
Official title Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression
ClinicalTrials.gov ID: NCT05377463
What this study is testing
- What it's testing
- The study will test two behavioral intervention components to identify the combination of the two components that best supports people who inject drugs to achieve and sustain HIV viral load suppression. The study design is a 2-to-the-2 factorial experiment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- be at least 18 years of age
- be able to provide informed consent
- be eligible to receive free HIV care services in Mexico
- be HIV positive
- have injected drugs in the last 30 days
You likely can't join if
- has not injected drugs in the last 30 days or do not have a verifiable opioid use disorder
- is not HIV positive
- is receiving methadone
- is unwilling to discuss methadone uptake with a peer
- does not screen positive for depression
- is not able to provide informed consent
See the full eligibility criteria
- be at least 18 years of age
- be able to provide informed consent
- be eligible to receive free HIV care services in Mexico
- be HIV positive
- have injected drugs in the last 30 days
- not be on methadone replacement therapy
- be willing to discuss MAT uptake with a peer
- sign a medical release form to have medical data abstracted
- agree to submit and describe locator information
- agree to return to follow-up visits
- able to communicate in Spanish
- screen positive for depression on the PHQ-2
- have no plans of moving outside the study area in the next 12-months
- meet one of the following:
- not currently in possession of ART or not taking ART but prescribed ART or
- sub-optimal ART adherence as at least one 4-day treatment interruption in the past 90 days or
- sub-optimal retention in HIV care - never engaged or disengaged from HIV care as 2 or more missed clinic appointments in the last 9 months or
- no viral load test done in the past six months or
- self-reports a detectable viral load within the past 6 months
- has not injected drugs in the last 30 days or do not have a verifiable opioid use disorder
- is not HIV positive
- is receiving methadone
- is unwilling to discuss methadone uptake with a peer
- does not screen positive for depression
- is not able to provide informed consent
- does not speak Spanish
- has plans to move out of the city
- does not qualify to receive free HIV care services in Mexico
- has an appearance of psychological disturbance or severe cognitive impairment that could limit understanding of study procedures as determined by study staff
The study team makes the final eligibility decision.
Where it's taking place
- Ciudad Juárez, Chihuahua, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ciudad Juárez, Chihuahua, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.